ARIDIS PHARMACEUTICALS, INC.

Insiders Aridis Pharmaceuticals, Inc.

Equities

ARDS

US0403341045

Market Closed - OTC Markets Other stock markets 02:59:13 2024-07-12 pm EDT			5-day change	1st Jan Change
0.06 ^USD	+8.89%		-21.57%	-14.41%

Jun. 24	Aridis Pharmaceuticals, Inc. Provides Corporate Update on Recent Developments	CI
Jun. 24	Aridis Pharmaceuticals, Inc. announced that it expects to receive $0.299 million in funding	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aridis Pharmaceuticals, Inc. Announces Resignation as Chief Financial Officer	23-08-09	CI
Aridis Pharmaceuticals, Inc. Announces the Resignation of Robert Ruffolo as Director	23-03-22	CI
Aridis Pharmaceuticals, Inc. Announces Executive Appointments	20-06-15	CI
Aridis Pharmaceuticals Announces Executive Changes	19-10-11	CI
Aridis Pharmaceuticals, Inc. Appoints Susan Windham-Bannister to Board of Directors	19-06-10	CI
Aridis Pharmaceuticals, Inc. Appoints Two Executives	18-03-05	CI
Aridis Pharmaceuticals, Inc. Appoints Alan H. Cohen as Senior Vice President of Clinical & Medical Affairs	17-08-07	CI
Aridis Pharmaceuticals Inc. Announces Appointments to Clinical Advisory Board	16-07-11	CI
Aridis Pharmaceuticals Appoints Robert Ruffolo to its Board of Directors	16-04-18	CI
Aridis Pharmaceuticals Inc. Appoints Fred Kurland as Chief Financial Officer	15-07-14	CI
Aridis Pharmaceuticals Inc. Appoints Craig Gibbs to Board of Directors	15-04-09	CI
Aridis Pharmaceuticals Inc. Appoints Paul-Andre de Lame as Chief Medical Officer	15-03-23	CI
Aridis Pharmaceuticals, Inc. Appoints Steven Opal to its Scientific Advisory Board	14-11-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer